← Eichor
Study identifier: NCT06277297 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Prognotic Role of CMR in Takotsubo Syndrome

Condition: Takotsubo Cardiomyopathy · Machine Learning · Magnetic Resonance Imaging  ·  Sponsor: University of Cagliari

PhaseN/A
Planned participants350
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The primary objective of this observational registry is to develop a comprehensive clinical and imaging score (incorporating echocardiography and cardiac magnetic resonance data) that enhances risk stratification for patients with Takotsubo syndrome. The secondary objectives of this registry are as follows: Investigate the diagnostic value of cardiac magnetic resonance parameters in predicting in-hospital and long-term outcomes in patients with Takotsubo syndrome. Compare the proposed risk stratification score for patients with Takotsubo syndrome with previously existing scores. Investigate the contribution of machine learning models in predicting in-hospital and long-term outcomes compared to standard clinical scores. The design and rationale of this registry are available at 10.1097/RTI.0000000000000709

This description comes directly from the study's public registry record.

Talk to the study team

Riccardo Cau, MD  ·  +3393493317  ·  riccardo.cau@unica.it

Always discuss trial participation with your own doctor first.

Locations (1)

University of CagliariCagliari, Italy, ItalyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06277297